Skip to main content

Tykerb News

GSK's Tykerb Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer

PHILADELPHIA, Jan. 29 /PRNewswire/ – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using Tykerb...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Metastatic, Breast Cancer

Tykerb patient information at Drugs.com